Allergen-specific immunotherapy offers the possibility of lasting remission from environmental allergies in dogs, representing a welfare-positive alternative to lifetime symptomatic management.
Allergen immunotherapy represents a qualitative welfare improvement over symptom suppression — it addresses the root cause of chronic itch rather than merely masking it. Dogs achieving good ASIT responses experience relief from chronic pruritus without the need for continuous pharmaceutical intervention. The welfare investment involves months of injections (mild discomfort) before benefit is realized, but for dogs with moderate to severe atopic dermatitis, this investment yields years of improved quality of life. Owner compliance with the injection schedule is the primary barrier to success. Veterinary dermatologists report that the majority of atopic dogs who complete ASIT protocol achieve meaningful quality-of-life improvement, making early referral for allergy testing an important welfare intervention.